MAGNESIUM

MAGNESIUM was reported 441658 times

These side effects are most commonly reported by patients taking MAGNESIUM:

# Side effect Count
0 FATIGUE 9211
1 NAUSEA 7182
2 DIARRHOEA 7024
3 HEADACHE 6359
4 DRUG INEFFECTIVE 5956
5 PAIN 5682
6 OFF LABEL USE 5385
7 DIZZINESS 5306
8 DYSPNOEA 5252
9 ARTHRALGIA 4916
10 ASTHENIA 4515
11 VOMITING 3971
12 MALAISE 3532
13 PAIN IN EXTREMITY 3475
14 RASH 3404
15 FALL 3277
16 MUSCLE SPASMS 3271
17 INSOMNIA 3261
18 PRURITUS 3253
19 WEIGHT DECREASED 3171
20 PNEUMONIA 3117
21 ANXIETY 2862
22 DECREASED APPETITE 2835
23 COUGH 2832
24 PYREXIA 2830
25 WEIGHT INCREASED 2830
26 CONSTIPATION 2725
27 ABDOMINAL PAIN UPPER 2670
28 CONDITION AGGRAVATED 2610
29 GAIT DISTURBANCE 2555
30 BACK PAIN 2526
31 NASOPHARYNGITIS 2461
32 DEATH 2431
33 PERIPHERAL SWELLING 2423
34 ALOPECIA 2343
35 DEPRESSION 2337
36 HYPERTENSION 2311
37 HYPOAESTHESIA 2266
38 ABDOMINAL DISCOMFORT 2245
39 PRODUCT DOSE OMISSION ISSUE 2211
40 PARAESTHESIA 2193
41 FEELING ABNORMAL 2160
42 CHEST PAIN 2142
43 ABDOMINAL PAIN 2129
44 URINARY TRACT INFECTION 1985
45 SINUSITIS 1957
46 JOINT SWELLING 1932
47 MEMORY IMPAIRMENT 1898
48 CONFUSIONAL STATE 1875
49 PRODUCT USE IN UNAPPROVED INDICATION 1838
50 DRUG HYPERSENSITIVITY 1809
51 MYALGIA 1807
52 MIGRAINE 1783
53 CONTUSION 1719
54 COVID-19 1718
55 MUSCULAR WEAKNESS 1717
56 BLOOD PRESSURE INCREASED 1664
57 HYPERSENSITIVITY 1612
58 URTICARIA 1589
59 INFECTION 1586
60 DRY MOUTH 1570
61 GENERAL PHYSICAL HEALTH DETERIORATION 1570
62 ANAEMIA 1534
63 RHEUMATOID ARTHRITIS 1525
64 HYPOTENSION 1496
65 MUSCULOSKELETAL STIFFNESS 1481
66 DYSPEPSIA 1480
67 MOBILITY DECREASED 1480
68 SWELLING 1456
69 PRODUCT USE ISSUE 1448
70 INFUSION RELATED REACTION 1419
71 SLEEP DISORDER 1417
72 TREMOR 1385
73 DRUG INTOLERANCE 1381
74 OEDEMA PERIPHERAL 1368
75 STOMATITIS 1363
76 SOMNOLENCE 1360
77 DEHYDRATION 1344
78 INJECTION SITE PAIN 1343
79 MATERNAL EXPOSURE DURING PREGNANCY 1335
80 GASTROINTESTINAL DISORDER 1315
81 ARTHROPATHY 1313
82 ASTHMA 1283
83 PALPITATIONS 1258
84 PSORIATIC ARTHROPATHY 1253
85 HEPATIC ENZYME INCREASED 1251
86 BLOOD CHOLESTEROL INCREASED 1225
87 ABDOMINAL DISTENSION 1224
88 BLISTER 1224
89 WHEEZING 1214
90 NEUROPATHY PERIPHERAL 1205
91 GASTROOESOPHAGEAL REFLUX DISEASE 1193
92 OEDEMA 1192
93 MUSCULOSKELETAL PAIN 1184
94 ERYTHEMA 1169
95 VISION BLURRED 1165
96 OSTEOARTHRITIS 1161
97 DISCOMFORT 1158
98 HEART RATE INCREASED 1156
99 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1151
100 INTENTIONAL PRODUCT USE ISSUE 1138
101 BALANCE DISORDER 1108
102 CHILLS 1091
103 VISUAL IMPAIRMENT 1081
104 INJURY 1080
105 ATRIAL FIBRILLATION 1067
106 FIBROMYALGIA 1063
107 WOUND 1039
108 SYSTEMIC LUPUS ERYTHEMATOSUS 1032
109 TYPE 2 DIABETES MELLITUS 1032
110 WHITE BLOOD CELL COUNT DECREASED 1023
111 GLOSSODYNIA 992
112 PEMPHIGUS 983
113 PERICARDITIS 975
114 SYNOVITIS 972
115 IMPAIRED HEALING 970
116 NIGHT SWEATS 964
117 PLATELET COUNT DECREASED 964
118 ARTHRITIS 959
119 LUNG DISORDER 959
120 HYPERHIDROSIS 958
121 LOWER RESPIRATORY TRACT INFECTION 958
122 GAIT INABILITY 951
123 LIVER INJURY 945
124 HAEMOGLOBIN DECREASED 944
125 CHEST DISCOMFORT 939
126 IRRITABLE BOWEL SYNDROME 939
127 INFLUENZA 938
128 OROPHARYNGEAL PAIN 934
129 ILLNESS 931
130 THERAPEUTIC PRODUCT EFFECT DECREASED 919
131 BRONCHITIS 895
132 ACUTE KIDNEY INJURY 887
133 DRY SKIN 883
134 INCORRECT DOSE ADMINISTERED 880
135 DUODENAL ULCER PERFORATION 872
136 TREATMENT FAILURE 859
137 NECK PAIN 853
138 CONTRAINDICATED PRODUCT ADMINISTERED 848
139 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 847
140 HOT FLUSH 846
141 FOLLICULITIS 837
142 EYE PAIN 836
143 BLOOD GLUCOSE INCREASED 835
144 AMNESIA 833
145 FLUSHING 819
146 DRUG INTERACTION 818
147 HELICOBACTER INFECTION 814
148 RENAL FAILURE 813
149 SCIATICA 810
150 HAND DEFORMITY 809
151 LOSS OF CONSCIOUSNESS 804
152 PRODUCT QUALITY ISSUE 778
153 RHEUMATIC FEVER 777
154 MUSCLE INJURY 776
155 ILL-DEFINED DISORDER 773
156 LIVER DISORDER 767
157 ADVERSE DRUG REACTION 761
158 INFLAMMATION 745
159 DYSPHAGIA 743
160 ROAD TRAFFIC ACCIDENT 738
161 BURSITIS 727
162 JOINT RANGE OF MOTION DECREASED 723
163 SEPSIS 720
164 SYNCOPE 714
165 HOSPITALISATION 708
166 STRESS 707
167 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 703
168 THERAPY NON-RESPONDER 703
169 FEELING HOT 691
170 FLATULENCE 690
171 BONE PAIN 686
172 EPISTAXIS 677
173 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 675
174 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 666
175 BURNING SENSATION 664
176 OXYGEN SATURATION DECREASED 662
177 WOUND INFECTION 655
178 RHINORRHOEA 654
179 RHEUMATOID FACTOR POSITIVE 649
180 LOWER LIMB FRACTURE 648
181 CATARACT 641
182 CEREBROVASCULAR ACCIDENT 638
183 TASTE DISORDER 637
184 C-REACTIVE PROTEIN ABNORMAL 636
185 SEIZURE 636
186 INFLUENZA LIKE ILLNESS 633
187 LIP DRY 626
188 THROMBOCYTOPENIA 625
189 HALLUCINATION 623
190 PRODUCTIVE COUGH 623
191 THROMBOSIS 617
192 FLUID RETENTION 615
193 CROHN^S DISEASE 614
194 BLOOD PRESSURE DECREASED 610
195 PSORIASIS 609
196 EXPOSURE DURING PREGNANCY 608
197 OSTEOPOROSIS 607
198 SWOLLEN JOINT COUNT INCREASED 606
199 AUTOIMMUNE DISORDER 603
200 DRUG DOSE OMISSION 602
201 TACHYCARDIA 598
202 C-REACTIVE PROTEIN INCREASED 591
203 DYSPHONIA 588
204 ADVERSE EVENT 584
205 CHRONIC KIDNEY DISEASE 581
206 OBESITY 577
207 DYSGEUSIA 573
208 DRY EYE 569
209 CARDIAC DISORDER 567
210 PERIPHERAL VENOUS DISEASE 565
211 TINNITUS 564
212 PULMONARY FIBROSIS 559
213 UPPER RESPIRATORY TRACT INFECTION 555
214 NASAL CONGESTION 554
215 NEUTROPENIA 553
216 SUICIDAL IDEATION 552
217 DEEP VEIN THROMBOSIS POSTOPERATIVE 551
218 RECTAL HAEMORRHAGE 550
219 BLOOD MAGNESIUM DECREASED 549
220 DISTURBANCE IN ATTENTION 549
221 FEBRILE NEUTROPENIA 549
222 RENAL IMPAIRMENT 549
223 MYOCARDIAL INFARCTION 526
224 SKIN EXFOLIATION 525
225 VERTIGO 524
226 THERAPY INTERRUPTED 523
227 PRODUCT SUBSTITUTION ISSUE 520
228 BREAST CANCER STAGE III 517
229 PRESCRIBED OVERDOSE 515
230 INJECTION SITE ERYTHEMA 513
231 BLOOD CREATININE INCREASED 512
232 HAEMATOCHEZIA 510
233 RASH PRURITIC 508
234 CELLULITIS 507
235 HAEMORRHAGE 502
236 LIVE BIRTH 502
237 DYSPNOEA EXERTIONAL 500
238 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 497
239 DELIRIUM 491
240 FACET JOINT SYNDROME 490
241 FREQUENT BOWEL MOVEMENTS 490
242 EAR INFECTION 483
243 INJECTION SITE BRUISING 483
244 BLOOD POTASSIUM DECREASED 481
245 CARDIAC FAILURE CONGESTIVE 478
246 EYE IRRITATION 477
247 PULMONARY EMBOLISM 477
248 HERPES ZOSTER 475
249 UNEVALUABLE EVENT 470
250 LETHARGY 463
251 DISEASE PROGRESSION 456
252 THERAPY CESSATION 456
253 JOINT STIFFNESS 450
254 GRIP STRENGTH DECREASED 449
255 COLITIS ULCERATIVE 445
256 HEART RATE DECREASED 442
257 WHITE BLOOD CELL COUNT INCREASED 442
258 COGNITIVE DISORDER 441
259 HYPERCHOLESTEROLAEMIA 435
260 INTENTIONAL PRODUCT MISUSE 432
261 MALIGNANT NEOPLASM PROGRESSION 432
262 EPILEPSY 430
263 THROAT IRRITATION 429
264 EAR PAIN 425
265 NEPHROLITHIASIS 425
266 HYPOKALAEMIA 423
267 PANCREATITIS 423
268 CARDIAC FAILURE 420
269 SEASONAL ALLERGY 414
270 LABORATORY TEST ABNORMAL 413
271 MULTIPLE SCLEROSIS RELAPSE 413
272 CYSTITIS 412
273 KNEE ARTHROPLASTY 411
274 THERAPEUTIC RESPONSE DECREASED 410
275 GASTROINTESTINAL HAEMORRHAGE 408
276 POLLAKIURIA 406
277 RESPIRATORY DISORDER 406
278 SPEECH DISORDER 406
279 BLEPHAROSPASM 404
280 SWELLING FACE 403
281 DEPRESSED MOOD 402
282 RENAL DISORDER 402
283 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 401
284 PLEURAL EFFUSION 399
285 RED BLOOD CELL COUNT DECREASED 399
286 NERVOUSNESS 395
287 UNDERDOSE 394
288 PRESCRIBED UNDERDOSE 389
289 TOXICITY TO VARIOUS AGENTS 387
290 PAIN IN JAW 386
291 DEVICE ISSUE 385
292 PANIC ATTACK 382
293 HEPATIC CIRRHOSIS 377
294 ARRHYTHMIA 375
295 IRRITABILITY 374
296 NEURALGIA 372
297 LIMB DISCOMFORT 369
298 SKIN DISCOLOURATION 369
299 FOETAL EXPOSURE DURING PREGNANCY 367
300 DIABETES MELLITUS 365
301 HIP ARTHROPLASTY 363
302 LIMB INJURY 359
303 LUPUS VULGARIS 359
304 OVERDOSE 359
305 AGITATION 355
306 LIVER FUNCTION TEST INCREASED 355
307 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 354
308 DYSSTASIA 353
309 EXOSTOSIS 353
310 PRODUCT DOSE OMISSION 351
311 DYSKINESIA 348
312 HYPONATRAEMIA 348
313 VIRAL INFECTION 345
314 DIVERTICULITIS 343
315 DISLOCATION OF VERTEBRA 339
316 OCULAR HYPERAEMIA 338
317 BLOOD PRESSURE FLUCTUATION 337
318 FEELING COLD 336
319 RESPIRATORY FAILURE 336
320 CARDIAC ARREST 333
321 MULTIPLE SCLEROSIS 333
322 COLITIS 330
323 INJECTION SITE REACTION 326
324 ECZEMA 324
325 HYPERSOMNIA 324
326 LARYNGITIS 323
327 INJECTION SITE HAEMORRHAGE 322
328 POOR QUALITY SLEEP 322
329 NAIL DISORDER 321
330 THERAPEUTIC RESPONSE UNEXPECTED 321
331 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 320
332 BRAIN FOG 318
333 INTESTINAL OBSTRUCTION 317
334 PREGNANCY 316
335 SKIN DISORDER 316
336 FUNGAL INFECTION 315
337 HYPOMAGNESAEMIA 315
338 PULMONARY OEDEMA 313
339 INJECTION SITE PRURITUS 311
340 PANCYTOPENIA 311
341 RESPIRATORY TRACT INFECTION 309
342 INFUSION SITE PAIN 308
343 PLASMA CELL MYELOMA 307
344 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 305
345 MOVEMENT DISORDER 304
346 X-RAY ABNORMAL 304
347 MEDICATION ERROR 303
348 LACRIMATION INCREASED 302
349 ULCER HAEMORRHAGE 302
350 SURGERY 299
351 INJECTION SITE SWELLING 298
352 URINARY INCONTINENCE 297
353 ALANINE AMINOTRANSFERASE INCREASED 296
354 DEEP VEIN THROMBOSIS 296
355 FOOT DEFORMITY 296
356 RESTLESSNESS 294
357 LYMPHADENOPATHY 293
358 IMPAIRED WORK ABILITY 292
359 PHOTOPHOBIA 292
360 BACK INJURY 290
361 HIP FRACTURE 290
362 SINUS DISORDER 290
363 HEART RATE IRREGULAR 289
364 PRODUCT DOSE OMISSION IN ERROR 287
365 ORAL PAIN 283
366 ELECTROCARDIOGRAM QT PROLONGED 282
367 HEAD INJURY 280
368 CRYING 279
369 MUSCLE TWITCHING 279
370 NO ADVERSE EVENT 279
371 WITHDRAWAL SYNDROME 278
372 DYSURIA 277
373 CHOLELITHIASIS 276
374 TREATMENT NONCOMPLIANCE 274
375 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 273
376 NEUTROPHIL COUNT DECREASED 273
377 RESTLESS LEGS SYNDROME 273
378 WALKING AID USER 273
379 HYPOTHYROIDISM 272
380 RASH ERYTHEMATOUS 272
381 DISORIENTATION 268
382 NIGHTMARE 266
383 WEIGHT FLUCTUATION 266
384 BLOOD PRESSURE SYSTOLIC INCREASED 263
385 EYE SWELLING 263
386 APLASTIC ANAEMIA 262
387 BRADYCARDIA 262
388 LEUKOPENIA 262
389 EMOTIONAL DISTRESS 261
390 FULL BLOOD COUNT DECREASED 261
391 INTENTIONAL DOSE OMISSION 261
392 EYE DISORDER 260
393 HYPOXIA 260
394 PREMATURE BABY 260
395 TRANSIENT ISCHAEMIC ATTACK 259
396 HYPOCALCAEMIA 258
397 TOOTH DISORDER 256
398 C-REACTIVE PROTEIN 254
399 INTERVERTEBRAL DISC PROTRUSION 253
400 ASPARTATE AMINOTRANSFERASE INCREASED 252
401 PARAESTHESIA ORAL 252
402 BLOOD IRON DECREASED 251
403 EYE PRURITUS 251
404 HYPOACUSIS 250
405 RED BLOOD CELL SEDIMENTATION RATE INCREASED 250
406 PROCEDURAL PAIN 249
407 LOCALISED INFECTION 248
408 BONE EROSION 247
409 ORAL HERPES 247
410 ANAPHYLACTIC REACTION 246
411 MENTAL DISORDER 246
412 SLEEP APNOEA SYNDROME 246
413 HEAD DISCOMFORT 245
414 STAPHYLOCOCCAL INFECTION 245
415 TENDONITIS 242
416 RIB FRACTURE 241
417 DISEASE RECURRENCE 240
418 ACNE 235
419 APHASIA 235
420 BLOOD GLUCOSE DECREASED 235
421 MIDDLE INSOMNIA 234
422 ONYCHOMADESIS 234
423 JOINT DISLOCATION 233
424 MUCOSAL INFLAMMATION 233
425 RASH MACULAR 232
426 HYPOPHAGIA 231
427 JOINT INJURY 231
428 THERAPEUTIC RESPONSE SHORTENED 230
429 DEVICE MALFUNCTION 227
430 GASTRITIS 227
431 MUSCLE TIGHTNESS 227
432 CANDIDA INFECTION 223
433 KIDNEY INFECTION 223
434 BLOOD PRESSURE ABNORMAL 221
435 DERMATITIS ATOPIC 221
436 TENDON PAIN 221
437 BODY TEMPERATURE INCREASED 220
438 DYSARTHRIA 220
439 FEAR 220
440 INSURANCE ISSUE 217
441 MOOD SWINGS 216
442 ORAL CANDIDIASIS 215
443 PULMONARY HYPERTENSION 215
444 GASTROENTERITIS VIRAL 214
445 MACULAR DEGENERATION 213
446 NEOPLASM PROGRESSION 212
447 ANGER 210
448 FEEDING DISORDER 210
449 LIP SWELLING 210
450 BLOOD SODIUM DECREASED 208
451 HYPOGLYCAEMIA 208
452 LUPUS-LIKE SYNDROME 208
453 DIPLOPIA 207
454 DISABILITY 207
455 MUSCULOSKELETAL DISCOMFORT 207
456 ACCIDENTAL EXPOSURE TO PRODUCT 206
457 BREAST CANCER 206
458 HEPATIC STEATOSIS 206
459 RETINITIS 206
460 SKIN BURNING SENSATION 204
461 TOOTHACHE 204
462 HERNIA 202
463 INFUSION SITE REACTION 202
464 PRESYNCOPE 202
465 SNEEZING 202
466 AGEUSIA 201
467 GASTRIC DISORDER 201
468 CLOSTRIDIUM DIFFICILE INFECTION 200
469 NEOPLASM MALIGNANT 200
470 BLOOD URINE PRESENT 198
471 HAEMATOCRIT DECREASED 198
472 INFUSION SITE ERYTHEMA 198
473 NERVOUS SYSTEM DISORDER 197
474 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 196
475 RETCHING 196
476 HAEMORRHOIDS 195
477 IMMUNODEFICIENCY 194
478 SKIN LESION 193
479 DRUG TOLERANCE DECREASED 192
480 FOOT FRACTURE 192
481 SKIN ULCER 192
482 SKIN LACERATION 191
483 HAEMOPTYSIS 190
484 THIRST 190
485 BONE DENSITY DECREASED 189
486 MULTIPLE ALLERGIES 189
487 PREMATURE DELIVERY 187
488 RESPIRATORY TRACT CONGESTION 187
489 PARKINSON^S DISEASE 186
490 BACK DISORDER 185
491 OSTEOPENIA 185
492 URINARY RETENTION 185
493 BODY HEIGHT DECREASED 184
494 MENTAL IMPAIRMENT 184
495 BLOOD CALCIUM DECREASED 182
496 SPINAL FRACTURE 182
497 FAECES DISCOLOURED 181
498 IMPAIRED QUALITY OF LIFE 181
499 HAEMATOMA 179
500 HYPERKALAEMIA 179
501 INJECTION SITE MASS 179
502 MUSCULOSKELETAL CHEST PAIN 179
503 THYROID DISORDER 179
504 TOOTH INFECTION 179
505 SKIN FISSURES 178
506 DRUG-INDUCED LIVER INJURY 177
507 EMOTIONAL DISORDER 177
508 FEELING JITTERY 177
509 GOUT 176
510 MENTAL STATUS CHANGES 176
511 BASAL CELL CARCINOMA 175
512 SENSORY DISTURBANCE 175
513 ABDOMINAL PAIN LOWER 174
514 DRUG EFFECT DECREASED 174
515 SKIN CANCER 174
516 VENTRICULAR TACHYCARDIA 174
517 BREAST CANCER STAGE II 173
518 HALLUCINATION, VISUAL 173
519 SWOLLEN TONGUE 173
520 FEMUR FRACTURE 172
521 GLAUCOMA 172
522 ABNORMAL DREAMS 171
523 BLOOD COUNT ABNORMAL 171
524 INFUSION SITE SWELLING 171
525 MOUTH ULCERATION 171
526 PORPHYRIA ACUTE 171
527 ANGINA PECTORIS 170
528 CARPAL TUNNEL SYNDROME 170
529 HAEMATURIA 169
530 SEPTIC SHOCK 169
531 ACUTE RESPIRATORY FAILURE 168
532 ERUCTATION 168
533 PHOTOSENSITIVITY REACTION 168
534 VAGINAL HAEMORRHAGE 168
535 DRUG WITHDRAWAL SYNDROME 167
536 EATING DISORDER 167
537 MOOD ALTERED 167
538 CHROMATURIA 166
539 EYE INFECTION 165
540 HYPERLIPIDAEMIA 165
541 ASCITES 164
542 BLOOD ALKALINE PHOSPHATASE INCREASED 164
543 PRODUCT PRESCRIBING ERROR 164
544 BLOOD POTASSIUM INCREASED 163
545 DERMATITIS CONTACT 163
546 BLOOD CREATINE PHOSPHOKINASE INCREASED 162
547 DEVICE DISLOCATION 162
548 PERICARDIAL EFFUSION 162
549 GALLBLADDER DISORDER 161
550 NOCTURIA 161
551 OCULAR DISCOMFORT 161
552 THINKING ABNORMAL 161
553 THROAT TIGHTNESS 161
554 BACTERIAL INFECTION 160
555 MUSCLE ATROPHY 160
556 UPPER LIMB FRACTURE 160
557 LYMPHOCYTE COUNT DECREASED 159
558 POST PROCEDURAL COMPLICATION 159
559 PNEUMONITIS 157
560 SINUS CONGESTION 157
561 VAGINAL DISCHARGE 157
562 BLOOD TEST ABNORMAL 156
563 HYPOKINESIA 156
564 PRODUCT ADMINISTRATION ERROR 155
565 PRODUCT STORAGE ERROR 155
566 DEPRESSED LEVEL OF CONSCIOUSNESS 154
567 INTERNATIONAL NORMALISED RATIO INCREASED 154
568 MUSCULOSKELETAL DISORDER 154
569 SPINAL OSTEOARTHRITIS 154
570 DEAFNESS 152
571 ELECTROLYTE IMBALANCE 152
572 EXTRA DOSE ADMINISTERED 152
573 CHRONIC SINUSITIS 151
574 MULTIPLE ORGAN DYSFUNCTION SYNDROME 151
575 NEEDLE ISSUE 151
576 ROTATOR CUFF SYNDROME 151
577 APHONIA 150
578 BODY TEMPERATURE DECREASED 150
579 DECREASED ACTIVITY 150
580 DIZZINESS POSTURAL 150
581 INCREASED TENDENCY TO BRUISE 150
582 SECRETION DISCHARGE 150
583 TRANSFUSION 150
584 VITAMIN D DEFICIENCY 150
585 DRY THROAT 149
586 MICTURITION URGENCY 149
587 ABNORMAL BEHAVIOUR 148
588 BONE DISORDER 148
589 IMPAIRED GASTRIC EMPTYING 148
590 INJECTION SITE RASH 148
591 QUALITY OF LIFE DECREASED 148
592 BLOOD BILIRUBIN INCREASED 147
593 DEVICE LEAKAGE 146
594 PRODUCT AVAILABILITY ISSUE 146
595 PULMONARY MASS 146
596 INTERVERTEBRAL DISC DEGENERATION 145
597 PAIN OF SKIN 145
598 AGGRESSION 144
599 END STAGE RENAL DISEASE 144
600 FULL BLOOD COUNT ABNORMAL 144
601 GLYCOSYLATED HAEMOGLOBIN INCREASED 143
602 HIATUS HERNIA 143
603 HYPERGLYCAEMIA 143
604 SCAR 143
605 ACTIVITIES OF DAILY LIVING IMPAIRED 141
606 BLOOD PRESSURE DIASTOLIC DECREASED 141
607 DRUG EFFECT INCOMPLETE 141
608 NERVE COMPRESSION 141
609 ANKLE FRACTURE 140
610 PERIPHERAL COLDNESS 140
611 CONJUNCTIVITIS 139
612 CYTOKINE RELEASE SYNDROME 139
613 HYPERCALCAEMIA 139
614 SMALL INTESTINAL OBSTRUCTION 139
615 BEDRIDDEN 138
616 SKIN HAEMORRHAGE 138
617 SKIN IRRITATION 138
618 CHOKING 137
619 COVID-19 PNEUMONIA 137
620 APATHY 136
621 RENAL INJURY 136
622 BLOOD UREA INCREASED 135
623 CORONARY ARTERY DISEASE 135
624 DENTAL CARIES 135
625 VENTRICULAR EXTRASYSTOLES 135
626 BLOOD CALCIUM INCREASED 134
627 MATERNAL EXPOSURE TIMING UNSPECIFIED 134
628 EXPIRED PRODUCT ADMINISTERED 133
629 LIGAMENT SPRAIN 133
630 MELAENA 133
631 ORTHOSTATIC HYPOTENSION 133
632 POOR VENOUS ACCESS 133
633 RADICULOPATHY 133
634 ANAL INCONTINENCE 132
635 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 132
636 BLINDNESS 132
637 HAEMATEMESIS 132
638 RENAL FAILURE ACUTE 132
639 RESPIRATORY DISTRESS 132
640 TEMPERATURE INTOLERANCE 132
641 LIVER FUNCTION TEST ABNORMAL 130
642 DERMATITIS 129
643 METABOLIC ACIDOSIS 129
644 PRODUCT USE COMPLAINT 129
645 UPPER-AIRWAY COUGH SYNDROME 129
646 GAMMA-GLUTAMYLTRANSFERASE INCREASED 128
647 MUSCLE STRAIN 128
648 INCREASED APPETITE 127
649 MUSCLE SPASTICITY 127
650 PALLOR 127
651 SARS-COV-2 TEST POSITIVE 127
652 VITAMIN D DECREASED 127
653 ACUTE MYOCARDIAL INFARCTION 126
654 GASTROINTESTINAL PAIN 126
655 CIRCULATORY COLLAPSE 125
656 COLD SWEAT 125
657 INITIAL INSOMNIA 125
658 PLATELET COUNT INCREASED 125
659 TOOTH ABSCESS 125
660 CYST 124
661 GLOMERULAR FILTRATION RATE DECREASED 124
662 GROIN PAIN 124
663 HYPOAESTHESIA ORAL 124
664 SPINAL PAIN 124
665 TENDON RUPTURE 124
666 DEMENTIA 123
667 MENISCUS INJURY 123
668 OSTEOMYELITIS 123
669 TENDON DISORDER 123
670 WRIST FRACTURE 123
671 EYE INJURY 122
672 GINGIVAL PAIN 122
673 HEPATITIS 122
674 IMMUNE SYSTEM DISORDER 122
675 ULCER 122
676 EJECTION FRACTION DECREASED 121
677 RASH PAPULAR 121
678 TOOTH FRACTURE 121
679 TORSADE DE POINTES 121
680 EAR DISCOMFORT 120
681 NERVE INJURY 120
682 TENDERNESS 120
683 BLOOD PRESSURE SYSTOLIC DECREASED 119
684 GRIP STRENGTH 119
685 LYMPHOEDEMA 119
686 NORMAL NEWBORN 119
687 BOWEL MOVEMENT IRREGULARITY 118
688 GENERALISED OEDEMA 118
689 GINGIVAL BLEEDING 118
690 HUNGER 118
691 INTENTIONAL OVERDOSE 116
692 ANHEDONIA 115
693 CEREBRAL HAEMORRHAGE 115
694 DELUSION 115
695 PURPURA 114
696 SUICIDE ATTEMPT 114
697 UNRESPONSIVE TO STIMULI 114
698 FAECES SOFT 113
699 FEMALE GENITAL TRACT FISTULA 113
700 FINGER DEFORMITY 113
701 GASTRIC ULCER 113
702 LUNG NEOPLASM MALIGNANT 113
703 MASS 113
704 PRODUCT PHYSICAL ISSUE 113
705 HEREDITARY ANGIOEDEMA 111
706 INTERSTITIAL LUNG DISEASE 111
707 ORAL DISCOMFORT 111
708 CORONARY ARTERY OCCLUSION 110
709 NODULE 110
710 FACIAL PAIN 109
711 ENCEPHALOPATHY 108
712 IMPAIRED DRIVING ABILITY 108
713 INJECTION SITE URTICARIA 108
714 PROCTITIS 108
715 SCAB 108
716 TUMOUR MARKER INCREASED 108
717 VISUAL ACUITY REDUCED 108
718 ACCIDENTAL OVERDOSE 107
719 DRUG DEPENDENCE 107
720 SPLENOMEGALY 107
721 APPETITE DISORDER 106
722 BACTERAEMIA 106
723 GASTROINTESTINAL INFECTION 106
724 INCONTINENCE 106
725 PRODUCT DISTRIBUTION ISSUE 106
726 BLOOD ALBUMIN DECREASED 105
727 CARBOHYDRATE ANTIGEN 125 INCREASED 105
728 INCORRECT PRODUCT ADMINISTRATION DURATION 105
729 PHARYNGEAL SWELLING 105
730 VITREOUS FLOATERS 105
731 BLADDER DISORDER 104
732 BLOOD PRESSURE SYSTOLIC ABNORMAL 104
733 DECREASED INTEREST 104
734 RALES 104
735 ABASIA 103
736 BLOOD TRIGLYCERIDES INCREASED 103
737 BREAST PAIN 103
738 EYE DISCHARGE 103
739 GASTROENTERITIS 103
740 HAIR TEXTURE ABNORMAL 103
741 ONYCHOCLASIS 103
742 PELVIC PAIN 103
743 PRURITUS GENERALISED 103
744 VAGINAL FLATULENCE 103
745 ADRENAL INSUFFICIENCY 102
746 ANGIOEDEMA 102
747 ATRIAL FLUTTER 102
748 HOSPICE CARE 102
749 METASTASES TO LIVER 102
750 DEVICE OCCLUSION 101
751 ON AND OFF PHENOMENON 101
752 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 101
753 PELVIC FRACTURE 101
754 RENAL CYST 101
755 SPUTUM DISCOLOURED 101
756 COMA 100
757 INFUSION SITE HAEMORRHAGE 100
758 PNEUMOTHORAX 100
759 DEFAECATION URGENCY 99
760 DRUG EFFECT LESS THAN EXPECTED 99
761 HYPERAESTHESIA 99
762 PSYCHOTIC DISORDER 99
763 CONVULSION 98
764 DEVICE RELATED INFECTION 98
765 EYE HAEMORRHAGE 98
766 SKIN INFECTION 98
767 SPINAL COMPRESSION FRACTURE 98
768 GLUCOSE TOLERANCE IMPAIRED 97
769 METASTASES TO BONE 97
770 BLOOD PRESSURE DIASTOLIC ABNORMAL 96
771 CARDIAC FLUTTER 96
772 COMPRESSION FRACTURE 96
773 LACTIC ACIDOSIS 96
774 PULMONARY ARTERIAL HYPERTENSION 96
775 PULMONARY THROMBOSIS 96
776 RHABDOMYOLYSIS 96
777 SKIN ABRASION 96
778 SLUGGISHNESS 96
779 HAIR COLOUR CHANGES 95
780 HEPATIC FAILURE 95
781 MITRAL VALVE INCOMPETENCE 95
782 PRODUCT ADMINISTRATION INTERRUPTED 95
783 PROSTATIC SPECIFIC ANTIGEN INCREASED 95
784 SPINAL DISORDER 95
785 ARTHROPOD BITE 94
786 INFUSION SITE PRURITUS 94
787 PNEUMONIA ASPIRATION 94
788 WRONG TECHNIQUE IN DRUG USAGE PROCESS 94
789 APHTHOUS ULCER 93
790 COORDINATION ABNORMAL 93
791 IMMUNOSUPPRESSION 93
792 PARANOIA 93
793 PHARYNGITIS 93
794 SEROTONIN SYNDROME 93
795 SQUAMOUS CELL CARCINOMA 93
796 UPPER GASTROINTESTINAL HAEMORRHAGE 93
797 CARDIOMEGALY 92
798 CLOSTRIDIUM DIFFICILE COLITIS 92
799 DEVICE DIFFICULT TO USE 92
800 FOOD ALLERGY 92
801 GENERALISED TONIC-CLONIC SEIZURE 92
802 HEMIPARESIS 92
803 MUSCLE RIGIDITY 92
804 SUPRAVENTRICULAR TACHYCARDIA 92
805 ABNORMAL FAECES 91
806 ARTERIOSCLEROSIS 91
807 EXPOSURE VIA SKIN CONTACT 91
808 ONYCHOMYCOSIS 91
809 SCRATCH 91
810 TACHYPNOEA 91
811 THERAPY CHANGE 91
812 HYPERTHYROIDISM 90
813 INFUSION SITE EXTRAVASATION 90
814 IRON DEFICIENCY ANAEMIA 90
815 LUNG INFECTION 90
816 POLYNEUROPATHY 90
817 RENAL PAIN 90
818 ABSCESS 89
819 EXERCISE TOLERANCE DECREASED 89
820 FLANK PAIN 89
821 JOINT EFFUSION 89
822 MALNUTRITION 89
823 NEPHROPATHY 89
824 PROTEINURIA 89
825 SHOCK 89
826 SPINAL STENOSIS 89
827 ABORTION SPONTANEOUS 88
828 ELECTRIC SHOCK SENSATION 88
829 SPONDYLITIS 88
830 BLOOD PRESSURE DIASTOLIC INCREASED 87
831 CARDIO-RESPIRATORY ARREST 87
832 FRACTURE 87
833 OROPHARYNGEAL DISCOMFORT 87
834 TOOTH LOSS 87
835 BLOOD GLUCOSE ABNORMAL 86
836 BLOOD THYROID STIMULATING HORMONE INCREASED 86
837 DRUG RESISTANCE 86
838 EYE INFLAMMATION 86
839 MULTIPLE FRACTURES 86
840 APPLICATION SITE ERYTHEMA 85
841 ATELECTASIS 85
842 ERECTILE DYSFUNCTION 85
843 EXTRASYSTOLES 85
844 JAUNDICE 85
845 SENSATION OF FOREIGN BODY 85
846 BIPOLAR DISORDER 84
847 FLUID OVERLOAD 84
848 INFUSION SITE DISCHARGE 84
849 LEUKOCYTOSIS 84
850 PANCREATITIS ACUTE 84
851 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 84
852 CONCUSSION 83
853 LARGE INTESTINE POLYP 83
854 DYSMENORRHOEA 82
855 URINE OUTPUT DECREASED 82
856 VENTRICULAR FIBRILLATION 82
857 LUMBAR VERTEBRAL FRACTURE 81
858 SKIN ATROPHY 81
859 TROPONIN INCREASED 81
860 VASCULAR DEVICE INFECTION 81
861 APPLICATION SITE PRURITUS 80
862 DECUBITUS ULCER 80
863 FAECES HARD 80
864 PHARYNGITIS STREPTOCOCCAL 80
865 RASH VESICULAR 80
866 RED CELL DISTRIBUTION WIDTH INCREASED 80
867 RESPIRATORY RATE INCREASED 80
868 SJOGREN^S SYNDROME 80
869 SKIN REACTION 80
870 CARDIOMYOPATHY 79
871 INCORRECT DRUG ADMINISTRATION DURATION 79
872 INTERNAL HAEMORRHAGE 79
873 LOCAL SWELLING 79
874 POST PROCEDURAL INFECTION 79
875 ANAPHYLACTIC SHOCK 78
876 CENTRAL NERVOUS SYSTEM LESION 78
877 COMPLICATION ASSOCIATED WITH DEVICE 78
878 ECONOMIC PROBLEM 78
879 HEPATIC ENZYME ABNORMAL 78
880 HEPATOMEGALY 78
881 MUSCLE DISORDER 78
882 OESOPHAGITIS 78
883 OSTEONECROSIS OF JAW 78
884 PULMONARY CONGESTION 78
885 APPLICATION SITE PAIN 77
886 BLOOD LACTATE DEHYDROGENASE INCREASED 77
887 COELIAC DISEASE 77
888 CYANOSIS 77
889 DEVICE USE ERROR 77
890 DRUG ADMINISTRATION ERROR 77
891 HYPERACUSIS 77
892 HYPERTRANSAMINASAEMIA 77
893 PROSTATE CANCER 77
894 RECALLED PRODUCT 77
895 RESPIRATORY SYNCYTIAL VIRUS INFECTION 77
896 HYPERVOLAEMIA 76
897 NEUTROPENIC SEPSIS 76
898 PRODUCT ADHESION ISSUE 76
899 RASH GENERALISED 76
900 SWELLING OF EYELID 76
901 TRANSAMINASES INCREASED 76
902 WHITE BLOOD CELL COUNT ABNORMAL 76
903 ACUTE MYELOID LEUKAEMIA 75
904 DRUG DOSE OMISSION BY DEVICE 75
905 ELECTROCARDIOGRAM ABNORMAL 75
906 EMPHYSEMA 75
907 INJECTION SITE DISCOLOURATION 75
908 PARANASAL SINUS DISCOMFORT 75
909 PNEUMONIA BACTERIAL 75
910 PSYCHOMOTOR HYPERACTIVITY 75
911 SINUS HEADACHE 75
912 SINUS TACHYCARDIA 75
913 SKIN MASS 75
914 SQUAMOUS CELL CARCINOMA OF SKIN 75
915 BRONCHOSPASM 74
916 CARDIOVASCULAR DISORDER 74
917 DIABETES MELLITUS INADEQUATE CONTROL 74
918 EYELID PAIN 74
919 OSTEONECROSIS 74
920 OVERWEIGHT 74
921 PERONEAL NERVE PALSY 74
922 PERSONALITY CHANGE 74
923 PRODUCT PRESCRIBING ISSUE 74
924 PRODUCT TASTE ABNORMAL 74
925 TOOTH EXTRACTION 74
926 BLOOD DISORDER 73
927 DEVICE BREAKAGE 73
928 INFUSION SITE BRUISING 73
929 MANIA 73
930 NASAL DRYNESS 73
931 OBSTRUCTIVE AIRWAYS DISORDER 73
932 PAROSMIA 73
933 SWOLLEN JOINT COUNT 73
934 DRUG LEVEL INCREASED 72
935 HEART RATE ABNORMAL 72
936 INABILITY TO AFFORD MEDICATION 72
937 MALIGNANT MELANOMA 72
938 DECREASED IMMUNE RESPONSIVENESS 71
939 RAYNAUD^S PHENOMENON 71
940 TRICUSPID VALVE INCOMPETENCE 71
941 TRIGGER FINGER 71
942 FOREIGN BODY SENSATION IN EYES 70
943 GASTROINTESTINAL INFLAMMATION 70
944 GRAFT VERSUS HOST DISEASE 70
945 HYPERKERATOSIS 70
946 LOW BIRTH WEIGHT BABY 70
947 LYMPHOPENIA 70
948 MYOSITIS 70
949 NASAL DISCOMFORT 70
950 NEUTROPHIL COUNT INCREASED 70
951 SERONEGATIVE ARTHRITIS 70
952 SYSTEMIC INFECTION 70
953 BONE MARROW FAILURE 69
954 ENERGY INCREASED 69
955 HYPOPHOSPHATAEMIA 69
956 PRE-EXISTING CONDITION IMPROVED 69
957 SEDATION 69
958 APPENDICITIS 68
959 CHOLECYSTECTOMY 68
960 DEVICE USE ISSUE 68
961 PARANASAL SINUS HYPERSECRETION 68
962 PROCTALGIA 68
963 COAGULOPATHY 67
964 FRUSTRATION TOLERANCE DECREASED 67
965 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 67
966 NEPHROGENIC ANAEMIA 67
967 ORAL DISORDER 67
968 PARALYSIS 67
969 PARTIAL SEIZURES 67
970 POSTOPERATIVE WOUND INFECTION 67
971 PRODUCT LABEL CONFUSION 67
972 STOMA SITE DISCHARGE 67
973 TENSION HEADACHE 67
974 UROSEPSIS 67
975 UTERINE LEIOMYOMA 67
976 ASPIRATION 66
977 DEVICE INFUSION ISSUE 66
978 HAEMOGLOBIN INCREASED 66
979 INCORRECT DRUG ADMINISTRATION RATE 66
980 MADAROSIS 66
981 MOTOR DYSFUNCTION 66
982 PETECHIAE 66
983 SINUS BRADYCARDIA 66
984 TRIGEMINAL NEURALGIA 66
985 VASCULITIS 66
986 ACUTE RESPIRATORY DISTRESS SYNDROME 65
987 BREAST MASS 65
988 FEELING OF BODY TEMPERATURE CHANGE 65
989 PRODUCT ODOUR ABNORMAL 65
990 TONGUE DISCOMFORT 65
991 DRUG PRESCRIBING ERROR 64
992 FORMICATION 64
993 GASTROINTESTINAL MOTILITY DISORDER 64
994 LACERATION 64
995 ODYNOPHAGIA 64
996 PANIC REACTION 64
997 PLANTAR FASCIITIS 64
998 SENSITIVE SKIN 64
999 STATUS EPILEPTICUS 64